Table 4
Clinical features of nine atypical cases
| Patient No | Sex/age (years) | Final diagnosis | Initial diagnosis | Results of Watzke–Allen test | Results of Amsler grid test | Results of SLO microperimetry | Initial visual acuity | Length of follow up (months) | Vitrectomy | Final visual acuity | Comments | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deep | Relative | ||||||||||||||||||||||
| 1 | F/56 | II MH | I MH | Normal | Meta | + | + | 20/40 | 20 | with FGX | 20/20 | Macular hole progressed | |||||||||||
| 2 | M/68 | II MH | I MH | Thinning | Meta | + | + | 20/40 | 19 | with FGX | 20/20 | ||||||||||||
| 3 | M/62 | II MH | EMP | Thinning | Meta | + | + | 20/20 | 16 | with FGX | 20/25 | ||||||||||||
| 4 | F/58 | II MH | I MH | Thinning | Meta | + | + | 20/40 | 12 | with FGX | 20/32 | Macular hole progressed | |||||||||||
| 5 | M/56 | I MH | II MH | Thinning | Scoto and meta | − | + | 20/16 | 17 | ND | 20/16 | ||||||||||||
| 6 | F/55 | I MH | II MH | Thinning | Scoto and meta | − | − | 20/20 | 16 | ND | 20/16 | ||||||||||||
| 7 | F/65 | EMP | II MH | Thinning | Meta | − | − | 20/60 | 21 | peeling | 20/32 | ||||||||||||
| 8 | M/44 | EMP | II MH | Normal | Meta | − | − | 20/40 | 17 | peeling | 20/20 | ||||||||||||
| 9 | F/61 | EMP | II MH | Normal | Meta | − | − | 20/32 | 17 | ND | 20/16 | Spontaneous PVD occurred | |||||||||||
-
I MH = impending macular hole; II MH = stage 2 macular hole; EMP = epimacular membrane with pseudohole; Meta = metamorphosia; scoto = scotoma; FGX = fluid gas exchange; ND = not done; peeling = membrane peeling; PVD = posterior vitreous detachment.
